Cigna Group (CI)

The Cigna Group's stock price has been influenced by strong fourth-quarter and full-year 2025 results, with adjusted income from operations increasing by 44% in Q4 2025 compared to Q4 2024. Full-year adjusted revenue for 2025 grew by 11% to $275 billion, and adjusted earnings per share increased by 9% to $29.84. Strategic moves impacting the stock include the sale of Cigna Healthcare's Medicare business, expansion of specialty capabilities through an investment in Shields Health Solutions, and a global settlement with the Federal Trade Commission (FTC). Cigna's stock price increased by 1.96% over the last 12 months and 2.93% in the past month, trading at $292.29 as of the latest close.

Demand seasonality for The Cigna Group's products and services is evident, particularly within its Cigna Healthcare division. The company anticipates that earnings seasonality will be consistent with previous years, with the first quarter typically accounting for over 30% of the full-year adjusted earnings expectations for the business. The medical care ratio (MCR) for Cigna Healthcare is also expected to show seasonality, with the first quarter MCR projected to be below 81% due to typical seasonal patterns. Additionally, stop-loss seasonality is a factor in Cigna Healthcare's net medical costs payable.

The Cigna Group is a global health services company focused on improving health and vitality through its Cigna Healthcare and Evernorth Health Services divisions. It offers a range of products and services, including medical, dental, disability, life, and accident insurance, as well as pharmacy benefits management, behavioral health programs, and supplemental health solutions. Cigna is strategically reducing its exposure to government programs and focusing on lower-cost biosimilars and streamlined care accessibility to drive growth in its Commercial business.

The Cigna Group has a significant global presence, serving over 178 million customer relationships in more than 30 countries and jurisdictions worldwide. Its corporate headquarters are in Bloomfield, Connecticut, with Cigna Global Health Benefits operations in Wilmington, Delaware, Visalia, California, Greenock, Scotland, Shanghai, China, and Antwerp, Belgium. The company also maintains sales offices across North America, Europe, Asia, and the Middle East.

The Cigna Group has emphasized its "Commitment to Better" initiative and its approach to ethical artificial intelligence (AI) practices. A global settlement with the Federal Trade Commission (FTC) is expected to provide $7 billion in out-of-pocket cost relief over the next decade. However, Cigna has also faced controversies, including allegations of automatically denying insurance claims without proper review.

The Cigna Group has a high level of institutional ownership, with approximately 89.83% of its shares held by institutions. Major institutional owners include Vanguard Group Inc., BlackRock, Inc., State Street Corp, Massachusetts Financial Services Co, and T. Rowe Price Group, Inc. Insider ownership stands at approximately 1.43%.